| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allied Corp. | Director, 10%+ Owner | Common Stock | 4.78M | $2.25M | $0.47 | 27 Apr 2023 | Direct |
| NYMOX PHARMACEUTICAL CORP | Director, 10%+ Owner | Common Stock | 4.78M | $2.25M | $0.47 | 27 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NYMXF | NYMOX PHARMACEUTICAL CORP | 25 Apr 2023 | 2 | $36.8K | 4/A | Director, 10%+ Owner | 26 Jun 2023, 10:27 |
| NYMXF | NYMOX PHARMACEUTICAL CORP | 25 Apr 2023 | 1 | $18K | 4/A | Director, 10%+ Owner | 18 May 2023, 16:09 |
| ALID | Allied Corp. | 25 Apr 2023 | 2 | $36.8K | 4 | Director, 10%+ Owner | 27 Apr 2023, 16:50 |
| NYMXF | NYMOX PHARMACEUTICAL CORP | 02 May 2022 | 2 | $1.9M | 4 | Director | 06 May 2022, 06:00 |